Emma Cahuzac is a Researcher for the Access to Medicine Foundation and is part of the New Programmes team. Her research focuses on the role of medical gas companies and generic medicine manufacturers in improving access to medicine.
Emma holds a BSc (Hons) in Natural Sciences from the University of Bath in the UK, where she majored in Pharmacology, and an MSc in Public Health from the London School of Hygiene and Tropical Medicine.
Prior to joining the Foundation, Emma spent a year conducting research in Molecular Psychiatry at Yale University School of Medicine in the USA. She subsequently spent four years working in Regulatory Affairs, including at a multinational pharmaceutical company, working within various global and local roles, with her main focus being on coordinating new product registrations.
Emma has also worked in Epidemiology at the UK Health Security Agency within the COVID-19 and influenza surveillance team.
